Ratings and dated fundamentals
Exact eligible report scores in ranking order. Ratings summarize dated reports, not future returns; report and market dates remain in the table. Showing the first 10 of 25 recorded values; the complete table remains available below.
See the complete ratings and dated fundamentals
Scroll sideways to compare all columns. Select a heading to sort.
| 1 | Idexx Laboratories Inc | IDXX | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $676.04 | $53,262,666,590.6 | 45.05 | 28.5 |
| 2 | ZOETIS INC. | ZTS | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $79.4 | $32,261,502,071.8 | 12.98 | 9.77 |
| 3 | Merck & Co., Inc. | MRK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $146.73 | $361,725,499,800.24 | 147.46 | Not reported |
| 4 | Oil-Dri Corporation of America | ODC | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $70.7 | $724,356,355.1 | 12.71 | 2.43 |
| 5 | Archer Daniels Midland Company | ADM | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $69.97 | $33,300,065,864.24 | 13.41 | 1.38 |
| 6 | Chewy, Inc. | CHWY | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $22.56 | $9,236,610,109.92 | 33.75 | 24.93 |
| 7 | Cencora, Inc. | COR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $333.56 | $63,652,309,157.4 | 24.25 | Not reported |
| 8 | Elanco Animal Health Incorporated Common Stock | ELAN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.74 | $12,865,548,704.58 | Not reported | 1.94 |
| 9 | Phibro Animal Health Corporation Class A | PAHC | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $32.96 | $1,338,228,834.88 | 13.03 | 3.2 |
| 10 | Immucell Corp | ICCC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.8 | $89,005,530.6 | 113.04 | 2.84 |
| 11 | Telus Corporation | TU | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9.11 | $14,348,250,000 | 25.78 | 1.19 |
| 12 | Petco Health and Wellness Company, Inc. Class A Common Stock | WOOF | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.96 | $959,662,008.48 | 31.7 | 0.8 |
| 13 | Zhengye Biotechnology Holding Limited Class A Ordinary Shares | ZYBT | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.5 | $71,087,064 | Not reported | 1.62 |
| 14 | Butterfly Network, Inc. | BFLY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.37 | $1,696,236,615.71 | Not reported | 9.2 |
| 15 | BGM Group Ltd. Class A Ordinary Shares | BGM | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $8.25 | $110,171,415.75 | Not reported | 0.28 |
| 16 | Neogen Corp | NEOG | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.76 | $2,567,278,959.84 | Not reported | 1.23 |
| 17 | PetMed Express, Inc. | PETS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.22 | $26,448,275.08 | Not reported | 1.15 |
| 18 | Sonoma Pharmaceuticals, Inc. Common Stock | SNOA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.11 | $5,315,151.75 | Not reported | 0.81 |
| 19 | cbdMD, Inc. Common Stock | YCBD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.42 | $4,661,298.72 | Not reported | 0.57 |
| 20 | Boqii Holding Limited | BQ | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.42 | $3,107,555.46 | Not reported | 0.12 |
| 21 | Cytosorbents Corp. | CTSO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.8 | $15,082,257.6 | Not reported | Not reported |
| 22 | Gelteq Limited Ordinary Shares | GELS | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.44 | $4,712,865.96 | Not reported | Not reported |
| 23 | Jaguar Health, Inc. | JAGX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.4 | $16,256.5 | Not reported | 0 |
| 24 | VolitionRx Limited | VNRX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.2 | $2,673,914.33 | Not reported | Not reported |
| 25 | Ainos, Inc. Common Stock | AIMD | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.7 | $5,154,082.95 | Not reported | 1.57 |
No matching rows. Clear the filter to see all records.
25 companies with eligible ratings and dated fundamentals, from 25 eligible companies in this selection.
Inspect the highest-rated company
Ratings and dated fundamentals
Veterinary: source evidence dated 2026-11-07T12:42:51.530Z.
- Rank
- 1
- Company
- Idexx Laboratories Inc
- Ticker
- IDXX
- Rating / 5
- 4
- Report date
- 2025-12-31
- Fiscal period
- 2025 FY
- Model
- anthropic/claude-haiku-5-5
- Market day
- 2026-11-06
The selected ticker, rating, report date and producing model match the first displayed row. Equal ratings use ticker order.
Which company leads this published industry selection?
The first row is highest by the stored 1-to-5 report rating, not forecast return. Check its report date, fiscal period and model.
NexusTrade stock ratings and report filters- Median market capitalization
- $724,356,355.1 · 25 / 25 displayed companies
- Median positive P/E (TTM)
- 25.78 · 11 / 25 displayed companies
- Median positive price / book
- 1.47 · 20 / 25 displayed companies
- Largest company by market cap
- Merck & Co., Inc. (MRK) · $361,725,499,800.24
- Largest company's share of displayed market cap
- 61.49% · Sum of displayed market caps; not portfolio weights or revenue exposure
Check each median’s included count and each company’s market date. These are unweighted summaries of displayed companies, not a sector index or revenue exposure.
Open this industry in the stock screener
Read the company's fundamentals and compare another dated report before treating equal ratings as equal businesses.
Open this industry in the stock screenerKeep reporting dates and units beside the answer, and inspect its original citations.
How is this ranking built?

Every industry list applies the same steps at its own cutoff: industry membership, the latest AI report rating on or before the cutoff, a report age limit, dated market data, then a sort by rating with ties ordered by ticker. The animation steps through them with one real example, the live cybersecurity list refreshed on October 13, 2026.
A live list's cutoff is its refresh time. A past year's list uses December 31 of the year before, and the current year's list uses the time it was generated. A Top N page shows the first N rows of its year's list and exists only when that list has at least N companies.
What best means in this list
This list was refreshed on 2026-11-07 using existing company reports. The report date in each row is the date of the underlying analysis; refreshing the list does not create a new company report.
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
Companies belong to the Veterinary classification, based on company products and revenue. Classifications can overlap, so a company may appear in several industry lists.
What the leading companies do
The first 5 companies below lead the ratings in this snapshot; equal ratings are ordered by ticker. Their company profiles describe different businesses even when they share the Veterinary selection.
These are company descriptions, not estimates of revenue from this theme. Industry membership does not identify a pure-play business or establish how much sales depend on it. Open the company profile and examine segment disclosures before treating an overlapping classification as equivalent exposure.
Idexx Laboratories Inc (IDXX): 4 / 5
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
ZOETIS INC. (ZTS): 4 / 5
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1950 and is headquartered in Parsippany, New Jersey.
Merck & Co., Inc. (MRK): 3.5 / 5
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Oil-Dri Corporation of America (ODC): 3.5 / 5
Oil-Dri Corporation of America, together with its subsidiaries, develops, manufactures, and markets sorbent products in the United States and internationally. It operates in two segments: Retail and Wholesale Products Group, and Business to Business Products Group. The company provides agricultural and horticultural products, including mineral-based absorbent products that serve as carriers for biological and chemical active ingredients, drying agents, and growing media under the Agsorb, Verge, and Flo-Fre brand names. It also offers animal health and nutrition products for the livestock industry; and adsorbent products for bleaching, purification, and filtration applications. In addition, it provides cat litter products under Saular brand name, such as scoopable and non-clumping litter under the Cat's Pride and Jonny Cat brand names; crystal cat litter products under Ultra and Litter Pearls brand names; Pro Mound packing clay is used to construct pitcher's mounds, catcher's stations and batter's boxes; Rapid Dry drying agent is used to wick away excess water from the infield; industrial and automotive sorbent products from clay, polypropylene, and recycled materials that absorb oil, acid, paint, ink, water, and other liquids under the Oil-Dri brand name; and sports products for use on baseball, softball, football, cricket, and soccer fields under the Pro's Choice brand name. Its customers include mass merchandisers, farm & fleet channel, drugstore chains, pet specialty retail outlets, dollar stores, retail grocery stores, distributors of industrial cleanup and automotive products, environmental service companies, and sports field product and sports turf material users; processors and refiners of edible oils, petroleum-based oils, and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; distributors of animal health and nutrition products; and marketers of consumer products. The company was founded in 1941 and is based in Chicago, Illinois.
Archer Daniels Midland Company (ADM): 3 / 5
Archer-Daniels-Midland Company engages in the procurement, transportation, storage, processing, and merchandising of agricultural commodities, ingredients, flavors, and solutions. It operates in three segments: Ag Services and Oilseeds; Carbohydrate Solutions; and Nutrition. The company originates, merchandises, stores, and transports agricultural raw materials, such as oilseeds and soft seeds. It engages in the agricultural commodity and feed product import, export, and distribution; and various structured trade finance activities. In addition, the company offers soybean meal and oil; vegetable and salad oils and protein meals; ingredients for the food, feed, energy, and industrial customers; margarine, shortening, and other food products; and partially refined oils to produce biodiesel and glycols for use in chemicals, paints, and other industrial products. Further, it provides peanuts, peanut-derived ingredients, and cotton cellulose pulp; sweeteners, corn and wheat starches, syrup, glucose, wheat flour, and dextrose; alcohol, and other food and animal feed ingredients; ethyl alcohol and ethanol; corn gluten feed and meal; distillers' grains; corn germ; and citric acids. Additionally, the company provides proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, and botanical extracts; and other specialty food and feed ingredients; edible beans; formula feeds, and animal health and nutrition products; and contract and private label pet treats and food products. It also offers futures commission merchant; commodity brokerage; cash margins and securities pledged to commodity exchange clearinghouse; and cash pledged as security under certain insurance arrangements. It operates in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. The company was founded in 1902 and is headquartered in Chicago, Illinois.
Valuation and company size within this selection
These summaries use the 25 displayed companies. Each company retains its own market observation date in the ratings table above. Medians are unweighted; they are not a sector index valuation.
Positive P/E and price-to-book values are summarized separately. Missing, zero and negative values are excluded from those medians, with the included count shown. A lower multiple alone does not establish better value: profitability, growth, debt and business mix can differ.
Show the table · 5 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Median market capitalization | $724,356,355.1 | 25 / 25 displayed companies |
| Median positive P/E (TTM) | 25.78 | 11 / 25 displayed companies |
| Median positive price / book | 1.47 | 20 / 25 displayed companies |
| Largest company by market cap | Merck & Co., Inc. (MRK) | $361,725,499,800.24 |
| Largest company's share of displayed market cap | 61.49% | Sum of displayed market caps; not portfolio weights or revenue exposure |
No matching rows. Clear the filter to see all records.
Other business classifications in the list
A company can appear in several product and revenue classifications. These overlapping memberships help identify different business mixes to investigate; they are not verified revenue shares or mutually exclusive subindustries.
Show the table · 5 rows, 2 columns
| Additional classification | Matching displayed companies |
|---|---|
| Healthcare | 19 / 25 |
| Manufacturing | 15 / 25 |
| Pharmaceuticals | 15 / 25 |
| Consumer Goods | 13 / 25 |
| Pet Care | 11 / 25 |
No matching rows. Clear the filter to see all records.
Dates and coverage
Report dates range from 2025-12-31 to 2025-12-31. Market observations range from 2026-11-06 to 2026-11-06. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 0 companies without a report, 0 with invalid latest rating metadata, 0 with older reports, 0 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.